medigraphic.com

2019, Number 2

<< Back Next >>

Rev Clin Esc Med 2019; 9 (2)

Generalidades de Enfermedad Celiaca y abordaje diagnóstico

Murillo SJA, Piedra CW, Sequeira CD, Sánchez MES, Sandoval LD

Language: Spanish
References: 12
Page: 64-69
PDF size: 400.97 Kb.


ABSTRACT

The celiac disease (CD) is a permanent Gluten intolerance, with a prevalence of 1%, which increases in people with autoimmune diseases, chromosomopathies, or first degree relatives with CD. Clinically it can be asymptomatic, or produce a florid malabsorption syndrome, with gastrointestinal and extra gastrointestinal symptoms, with impaired nutritional status. The diagnosis is made based on clinical suspicion, serological tests, genetic studies (HLA DQ2 / 8), and the duodenal biopsy, that is the gold standard for diagnosis. The treatment is maintaining a gluten-free diet for life.


REFERENCES

  1. Grupo de trabajo del Protocolo para el diagnóstico precoz de la enfermedad celíaca. Protocolo para el diagnóstico precoz de la enfermedad celíaca. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación del Servicio Canario de la Salud (SESCS). España, 2018. http://portal.guiasalud. es/contenidos/iframes/documentos/opbe/2018- 05/SESCS_2018_Protocolo_diag_precoz_EC.pdf Ministerio de Sanidad y Consumo España Diagnóstico precoz de la enfermedad celíaca Madrid

  2. Vaquero L Rodriguez L León F Jorquera F Vivas S. New coeliac disease treatments and their complications. Gastroenterol Hepatol. 2018;41(3):191-204. https://www.sciencedirect.com/ science/article/pii/S2444382418300415?via%3Dihub

  3. Rubio A Hill I Ciarán K Calderwood A Murray J. Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2013; 108:656–676; doi:10.1038/ ajg.2013.79.https://gi.org/guideline/diagnosis-andmanagement- of-celiac-disease/

  4. Kasper D Fauci A Hauser S Longo D Jameson J Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw Hill Companies, Inc. New Cork – U.S.A. 19th Edition, 2016: 1940-1942.

  5. Ciarán P Bai J Liu E Leffler D. Advances in Diagnosis and Management of Celiac Disease. Gastroenterology 2015;148:1175–1186. https://www. gastrojournal.org/article/S0016-5085(15)00162-6/fu lltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih. gov%2F

  6. Society for the Study of Celiac Disease (SSCD). CELIAC DISEASE DIAGNOSIS IN ADULTS. SSCD. Woodcreek- U.S.A. https://www.theceliacsociety. org/cd-adult_diagnosis_guide (Revisado 25 diciembre de 2018)

  7. Werkstetter K Korponay-Szabó R Popp A et al. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. Gastroenterology. 2017;153:924–935. https://www.ncbi.nlm.nih.gov/ pubmed/28624578

  8. Wolf J Petroff D Richter T et al. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy. Gastroenterology 2017;153:410–419. https://www.ncbi.nlm.nih.gov/ pubmed/28461188

  9. Fernández-Bañares F Esteve-Comas M Rosinach M. Cribado de la enfermedad celíaca en grupos de riesgo. Gastroenterol Hepatol. 2005;28(9):561-566

  10. Olivencia P Cano R Martín S León P Roy A Redondo V .Enfermedad celíaca del adulto y linfocitos intraepiteliales. ¿Nuevas opciones para el diagnóstico?. Gastroenterol Hepatol. 2008;31(9):555- 559.

  11. Fernándeza M Vivasa S Ruiz de Morales J Marugán J. Utilidad de los anticuerpos antitransglutaminasa en el diagnóstico de la enfermedad celíaca. Gastroenterol Hepatol. 2005;28(8):437-440.

  12. Sarna V Lundin K Mørkrid L Qiao S Sollid L Christophersen A. HLA-DQ–Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption. Gastroenterology 2018;154:886–896. https://www. gastrojournal.org/article/S0016-5085(17)36352-7/ fulltext




2020     |     www.medigraphic.com